arct-021
VaccineexperimentalCOVID-19
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Aug 4, 2020 (NCT04480957)
Timeline
Indications
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05037097 | Phase 1/Phase 2 (Phase 2) | Aug 30, 2021 | Arcturus Therapeutics |
| NCT04728347 | Phase 2 | Jan 4, 2021 | Arcturus Therapeutics |
| NCT04668339 | Phase 2 | Dec 27, 2020 | Arcturus Therapeutics |
| NCT04480957 | Phase 1/Phase 2 (Phase 2) | Aug 4, 2020 | Arcturus Therapeutics, SingHealth Investigational Medicine Unit |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Arcturus Therapeutics | For profit | 4 | 4 | 1 | 2020 |
| SingHealth Investigational Medicine Unit | For profit | 1 | 0 | 1 | 2020 |
2 organizations
Page 1 / 1